Mrv0541 01091514442D 10 9 0 0 0 0 999 V2000 11.5390 -6.6521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.8284 -7.0712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.1105 -6.6744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.4056 -7.0934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.6822 -6.6968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.9715 -7.1159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.5419 -5.8269 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.0976 -5.8495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.8398 -7.8962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.4199 -7.9183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 7 1 2 0 0 0 0 3 2 1 0 0 0 0 4 3 2 0 0 0 0 5 4 1 0 0 0 0 6 5 1 0 0 0 0 3 8 1 0 0 0 0 2 9 1 0 0 0 0 4 10 1 0 0 0 0 M END > CHEBI:84226 > (3E)-2,3,4-trimethylhex-3-enal > A hexenal that is (3E)-hex-3-enal substituted by methyl groups at positions 2, 3 and 6. Metabolite observed in cancer metabolism. > 3 > (3E)-2,3,4-trimethylhex-3-enal > C9H16O > 140.22270 > 140.12012 > 0 > CC\C(C)=C(/C)C(C)C=O > InChI=1S/C9H16O/c1-5-7(2)9(4)8(3)6-10/h6,8H,5H2,1-4H3/b9-7+ > BVVNPUJZXVWJAQ-VQHVLOKHSA-N > 25518943 $$$$